31st Annual Meeting of the Society for Virology

30 March – 2 April 2022 • hybrid

31st Annual Meeting of the Society for Virology

30 March – 2 April 2022 • hybrid

Conference Details

Transparency

Abbott GmbH: 1.800,00 €; altona Diagnostics GmbH: 3.500,00 €; Beckman Coulter Liefe Sciences: 2.400,00 €; Becton Dickinson GmbH: 2.850,00 €; BioLegend GmbH: 1.800 €; bioMérieux Deutschland GmbH: 3.600,00 €; Biomol GmbH: 350,00 €; BionTech SE: 5.000,00 €; Biozym Scientific GmbH: 350,00 €; DiaSorin Deutschland GmbH: 4.500,00 €; Genetic Signatures Ltd: 750,00 €; GeneTex International Corporation: 50,00 €; GlaxoSmithKline GmbH & Co. KG: 3.500 €; HiSS Diagnostics GmbH: 2.150,00 €; Invitek Molecular GmbH: 3.000 €; InvivoGen Europe: 500,00 €; Luminex - A DiaSorin Company: 2.100,00 €; Moderna: 13.900,00 €; MSD Sharp & Dohme GmbH: 3.500 €; New England BioLabs GmbH: 3.500,00 €; Promega GmbH: 5.050,00 €; Proteintech Germany GmbH: 1.800,00 €; R-Biopharm AG: 600,00 €; Roche Diagnostics Deutschland GmbH: 3.500,00 €; Seegene Germany GmbH: 4.500,00 €; Takara Bio Europe: 8.250,00 €